Table 4.
Cox Regression Analysis for Adverse Events in the Medication Group
| Predictors | P Value of PH Assumption | Univariate Analysis | Multivariate Analysis | ||
|---|---|---|---|---|---|
| Exp (B) (95% CI) | P Value | Exp (B) (95% CI) | P Value | ||
| Arrhythmia | 0.419 | 8.497 (1.895, 38.100) | 0.005 | 20.372 (2.232, 185.924) | 0.008 |
| Corrected RV EF, % | 0.301 | 0.839 (0.745, 0.946) | 0.004 | ··· | ··· |
| RV ESVI (10‐mL/m2 increment) | 0.636 | 1.190 (1.086, 1.304) | 0.000 | 1.151 (1.029, 1.287) | 0.014 |
| LV EF, % | 0.689 | 0.880 (0.815, 0.951) | 0.001 | ··· | ··· |
| LV ESVI (10‐mL/m2 increment) | 0.879 | 1.264 (1.103, 1.448) | 0.001 | ··· | ··· |
| TR degree | 0.424 | 3.797 (1.644, 8.770) | 0.002 | ··· | ··· |
| QRS duration (10‐ms increment) | 0.488 | 1.122 (1.044, 1.205) | 0.002 | ··· | ··· |
| Cardiothoracic ratio, % | 0.445 | 1.498 (1.115, 2.013) | 0.007 | ··· | ··· |
EF indicates ejection fraction; ESVI, end‐systolic volume index; LV, left ventricular; PH, proportional hazard; PRF, pulmonary regurgitation fraction; RV, right ventricular; TR, tricuspid regurgitation.